ATAI ATAI Life Sciences NV

Price (delayed)

$1.49

Market cap

$249.44M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.21

Enterprise value

$251.38M

Highlights
ATAI's EPS has soared by 78% year-on-year and by 16% since the previous quarter
The net income has soared by 77% YoY and by 16% from the previous quarter
The company's gross profit fell by 12% QoQ but it rose by 3% YoY
ATAI Life Sciences's revenue has decreased by 12% QoQ but it has increased by 3% YoY
ATAI's quick ratio is down by 43% year-on-year and by 17% since the previous quarter
The debt is up by 25% year-on-year and by 9% since the previous quarter

Key stats

What are the main financial stats of ATAI
Market
Shares outstanding
167.41M
Market cap
$249.44M
Enterprise value
$251.38M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.11
Price to sales (P/S)
854.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
907.49
Earnings
Revenue
$277,000
EBIT
-$30.23M
EBITDA
-$29.43M
Free cash flow
-$85.73M
Per share
EPS
-$0.21
Free cash flow per share
-$0.54
Book value per share
$1.34
Revenue per share
$0
TBVPS
$1.69
Balance sheet
Total assets
$269.12M
Total liabilities
$45.86M
Debt
$20.81M
Equity
$222.54M
Working capital
$102.49M
Liquidity
Debt to equity
0.09
Current ratio
7.83
Quick ratio
7.44
Net debt/EBITDA
-0.07
Margins
EBITDA margin
-10,624.9%
Gross margin
100%
Net margin
-12,203.2%
Operating margin
-42,000.7%
Efficiency
Return on assets
-12%
Return on equity
-14.3%
Return on invested capital
-14.3%
Return on capital employed
-11.9%
Return on sales
-10,914.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATAI stock price

How has the ATAI Life Sciences stock price performed over time
Intraday
0.68%
1 week
-7.45%
1 month
11.19%
1 year
-28.71%
YTD
5.67%
QTD
12.03%

Financial performance

How have ATAI Life Sciences's revenue and profit performed over time
Revenue
$277,000
Gross profit
$277,000
Operating income
-$116.34M
Net income
-$33.8M
Gross margin
100%
Net margin
-12,203.2%
The net margin has surged by 78% year-on-year and by 4.7% since the previous quarter
The net income has soared by 77% YoY and by 16% from the previous quarter
ATAI Life Sciences's operating margin has increased by 22% YoY but it has decreased by 5% from the previous quarter
ATAI Life Sciences's operating income has increased by 20% YoY and by 7% from the previous quarter

Growth

What is ATAI Life Sciences's growth rate over time

Valuation

What is ATAI Life Sciences stock price valuation
P/E
N/A
P/B
1.11
P/S
854.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
907.49
ATAI's EPS has soared by 78% year-on-year and by 16% since the previous quarter
The equity has declined by 8% since the previous quarter and by 6% year-on-year
ATAI Life Sciences's revenue has decreased by 12% QoQ but it has increased by 3% YoY

Efficiency

How efficient is ATAI Life Sciences business performance
The company's return on invested capital has surged by 84% YoY and by 33% QoQ
ATAI's ROS has soared by 79% year-on-year and by 6% since the previous quarter
The company's return on equity has surged by 74% YoY and by 15% QoQ
ATAI's ROA has soared by 74% year-on-year and by 15% since the previous quarter

Dividends

What is ATAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATAI.

Financial health

How did ATAI Life Sciences financials performed over time
ATAI's quick ratio is down by 43% year-on-year and by 17% since the previous quarter
The current ratio has contracted by 42% YoY and by 15% from the previous quarter
The debt is 91% smaller than the equity
The company's debt to equity rose by 29% YoY and by 13% QoQ
The debt is up by 25% year-on-year and by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.